Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

  1. Caronia, D.
  2. Patiño-García, A.
  3. Milne, R.L.
  4. Zalacain-Díez, M.
  5. Pita, G.
  6. Alonso, M.R.
  7. Moreno, L.T.
  8. Sierrasesumaga-Ariznabarreta, L.
  9. Benítez, J.
  10. Gonzáles-Neira, A.
Journal:
Pharmacogenomics Journal

ISSN: 1470-269X 1473-1150

Year of publication: 2009

Volume: 9

Issue: 5

Pages: 347-353

Type: Article

DOI: 10.1038/TPJ.2009.19 GOOGLE SCHOLAR

Sustainable development goals